https://www.selleckchem.com/pr....oducts/bms-986365.ht
On the basis of articles published in 2018, 2019 and 2020, the first aim of this review is to present estimates of incidence rates and excess mortality of overall cancer and organ-specific cancers for patients with schizophrenia compared with the general population.The second aim is to explore if underdiagnosis and undertreatment can explain - at least partly - the increased mortality of cancer in patients with schizophrenia compared with the general population. Patients diagnosed with schizophrenia have an approximately 50% increase
Like
Comment
Share
